Live Oak Health Sciences LOGSX

Medalist Rating as of | See Oak Associates Investment Hub
  • NAV / 1-Day Return 22.31  /  +0.22 %
  • Total Assets 54.3 Mil
  • Adj. Expense Ratio
    1.020%
  • Expense Ratio 1.020%
  • Distribution Fee Level Above Average
  • Share Class Type Institutional
  • Category Health
  • Investment Style Large Blend
  • Min. Initial Investment 2,000
  • Status Open
  • TTM Yield 0.59%
  • Turnover 47%

USD | NAV as of Sep 27, 2024 | 1-Day Return as of Sep 27, 2024, 10:16 PM GMT+0

Morningstar’s Analysis LOGSX

Will LOGSX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Live Oak Health Sciences’s Process Pillar rating is Average, but a strong management team still helps this strategy retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LOGSX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 45.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Regeneron Pharmaceuticals Inc

6.33 3.4 Mil
Healthcare

McKesson Corp

5.79 3.1 Mil
Healthcare

Amgen Inc

5.25 2.8 Mil
Healthcare

Cencora Inc

4.76 2.5 Mil
Healthcare

United Therapeutics Corp

4.49 2.4 Mil
Healthcare

Intuitive Surgical Inc

4.20 2.2 Mil
Healthcare

Elevance Health Inc

4.02 2.1 Mil
Healthcare

The Cigna Group

3.87 2.0 Mil
Healthcare

Exelixis Inc

3.57 1.9 Mil
Healthcare

Thermo Fisher Scientific Inc

3.52 1.9 Mil
Healthcare

Sponsor Center